Latest Close
$4.55
News
IRD
Opus Genetics, Inc. News
This news view pulls recent coverage and headlines tied to IRD.
1y Change
$3.57 (+364.29%)
Market Cap
$323,728,192.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Cantor Fitzgerald Initiates Opus Genetics at Overweight With $15 Price Target
MT Newswires • Mar 30, 2026
Read articleOpus Genetics Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
GlobeNewswire • Mar 24, 2026
Read articleOppenheimer Initiates Opus Genetics at Outperform With $10 Price Target
MT Newswires • Mar 16, 2026
Read articleWedbush Raises Price Target on Opus Genetics to $10 From $8, Keeps Outperform Rating
MT Newswires • Mar 12, 2026
Read articleChardan Raises Price Target on Opus Genetics to $11 From $9, Keeps Buy Rating
MT Newswires • Mar 12, 2026
Read articleBTIG Raises its Price Target on Opus Genetics, Inc. (IRD) to $12 from $7 and Maintains a Buy Rating
Insider Monkey • Mar 12, 2026
Read article